Elliptic Laboratories ASA
OSE:ELABS

Watchlist Manager
Elliptic Laboratories ASA Logo
Elliptic Laboratories ASA
OSE:ELABS
Watchlist
Price: 10.52 NOK -2.59% Market Closed
Market Cap: 1.1B NOK
Have any thoughts about
Elliptic Laboratories ASA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Elliptic Laboratories ASA

Current Assets 189.3m
Cash & Short-Term Investments 93.9m
Receivables 92.4m
Other Current Assets 3m
Non-Current Assets 167.1m
PP&E 18.5m
Intangibles 64.6m
Other Non-Current Assets 84m
Current Liabilities 25.7m
Accounts Payable 6.4m
Other Current Liabilities 19.4m
Non-Current Liabilities 13.2m
Long-Term Debt 13.2m

Balance Sheet
Elliptic Laboratories ASA

Rotate your device to view
Balance Sheet
Currency: NOK
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
35
14
33
99
217
176
116
Cash Equivalents
35
14
33
99
217
176
116
Total Receivables
10
20
21
18
47
47
67
Accounts Receivables
3
15
14
0
29
40
61
Other Receivables
6
6
7
18
18
7
6
Other Current Assets
3
3
2
5
1
2
6
Total Current Assets
47
37
56
122
265
226
186
PP&E Net
0
0
7
5
3
2
20
PP&E Gross
0
0
0
0
0
0
20
Accumulated Depreciation
0
0
0
0
0
0
0
Intangible Assets
3
10
17
28
37
48
58
Note Receivable
1
2
4
4
5
5
9
Other Long-Term Assets
47
53
56
60
63
69
78
Total Assets
98
N/A
102
+4%
139
+36%
219
+57%
371
+70%
349
-6%
350
+0%
Liabilities
Accounts Payable
1
3
1
1
3
2
4
Accrued Liabilities
6
7
8
6
8
9
13
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
4
43
31
6
7
6
8
Other Current Liabilities
2
2
0
0
0
0
0
Total Current Liabilities
13
55
40
14
18
17
25
Long-Term Debt
14
0
19
17
11
7
18
Other Liabilities
0
0
0
0
0
0
0
Total Liabilities
27
N/A
55
+106%
59
+8%
31
-48%
29
-7%
24
-17%
43
+81%
Equity
Common Stock
1
1
1
1
1
1
1
Additional Paid In Capital
2
6
71
175
343
346
355
Other Equity
69
40
9
13
1
21
49
Total Equity
72
N/A
47
-34%
80
+69%
188
+135%
343
+82%
326
-5%
307
-6%
Total Liabilities & Equity
98
N/A
102
+4%
139
+36%
219
+57%
371
+70%
349
-6%
350
+0%
Shares Outstanding
Common Shares Outstanding
86
86
88
96
104
104
105

See Also

Discover More